CYHS1800500 | 磺达肝癸钠注射液 | fondaparinux sodium | Injection | Chemical Drugs(4) | Generic Drug | 2019-01-02 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2021-02-05 | view |
CYHS2000798 | 那屈肝素钙注射液 | nadroparin calcium | Injection | Chemical Drugs(4) | Generic Drug | 2020-11-21 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-11-20 | view |
CYHS2000799 | 那屈肝素钙注射液 | nadroparin calcium | Injection | Chemical Drugs(4) | Generic Drug | 2020-11-21 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-11-20 | view |
CYHB1906892 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-13 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2020-08-03 | view |
CYHB1906893 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-13 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2020-08-03 | view |
CYSB2000051 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2020-04-04 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-04-03 | view |
CYSB2000052 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2020-04-04 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-04-03 | view |
CYHS1800496 | 曲前列尼尔注射液 | treprostinil | Injection | Chemical Drugs(4) | Generic Drug | 2018-12-25 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2020-03-19 | view |
CYHB1803332 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2018-06-25 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2018-11-09 | view |
CYHB1803333 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2018-06-25 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2018-11-09 | view |
CXHL1301074 | 生发肽滴眼液 | | Eye drops | Chemical Drugs(1.1) | New Drug Application | 2014-01-08 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2017-03-01 | view |
CXHL1301073 | 生发肽 | | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2014-01-08 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2017-03-01 | view |
CXHL1400468 | 司来普伐肽 | | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2014-08-01 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-19 | view |
CYHB1501868 | 低分子量肝素钙 | heparin calcium | Active ingredient | Chemical Drugs | Supplementary Application | 2015-08-12 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1400469 | 司来普伐肽凝胶 | | Gel | Chemical Drugs(1.1) | New Drug Application | 2014-08-01 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-19 | view |
CYHB1501872 | 注射用低分子量肝素钙 | heparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2015-08-12 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-19 | view |
CYHB1501871 | 注射用低分子量肝素钙 | heparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2015-08-12 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-19 | view |
CYSB1500092 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2015-06-01 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-04 | view |
CYSB1500093 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2015-06-01 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2016-05-04 | view |
CXHB0801599 | 小牛血去蛋白提取物眼凝胶 | | Gel | Chemical Drugs | Supplementary Application | 2009-01-08 | 兆科药业(合肥)有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2016-04-21 | view |